JM Research S.C
Cuernavaca, Morelos, Mexico
Research institute in Cuernavaca
Av Teopanzolco 217, Vista Hermosa, 62290 Cuernavaca, Mor.
About JM Research S.C
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
5
Shire
5
Eli Lilly and Company
2
Janssen Research & Development, LLC
2
AMAG Pharmaceuticals, Inc.
1
Appili Therapeutics Inc.
1
CanSino Biologics Inc.
1
Fulcrum Therapeutics
1
Galmed Research and Development, Ltd.
1
Laboratorios Liomont
1
Saint Luke's Health System
1
Clinical Trials at JM Research S.C
During the past decade, JM Research S.C conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 12 clinical trials were completed, i.e. on
average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 12 clinical trials were completed. i.e. 171.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH
2015-04-29
2018-05-22
Completed
247
AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH)
2017-04-05
2021-03-09
Terminated
1,778
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
2017-12-05
2020-10-06
Terminated
279
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
2018-02-27
2023-12-31
Active, not recruiting
557
An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
2018-04-04
2021-07-01
Completed
366
A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
2017-11-07
2025-12-22
Active, not recruiting
390
A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
2017-11-23
2019-08-16
Completed
660
A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis
2018-03-28
2023-08-07
Active, not recruiting
1,645
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "JM Research S.C" #1 sponsor was "Pfizer" with 5 trials, followed by "Shire" with 5 trials
sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "AMAG Pharmaceuticals, Inc."
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "JM Research S.C"
#1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Beijing Institute of Biotechnology" with 1 trials as a collaborator, "ClinIntel" with 1 trials as a collaborator and "Clinical Reference Laboratory" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were
collaborators in the rest 19 trials.
Clinical Trials Conditions at JM Research S.C
According to Clinical.Site data, the most researched conditions in "JM Research S.C" are
"COVID-19" (6 trials), "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Atopic Dermatitis" (2 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "JM Research S.C" in a lesser frequency.
Clinical Trials Intervention Types at JM Research S.C
Most popular intervention types in "JM Research S.C" are "Drug" (19 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "Ontamalimab" (4 trials), "Baricitinib" (2 trials), "PF-07321332" (2 trials) and "Ritonavir" (2 trials). Other intervention names were less common.
Clinical Trials Genders at JM Research S.C
The vast majority of trials in "JM Research S.C" are
22 trials for "All" genders.
Clinical Trials Status at JM Research S.C
Currently, there are NaN active trials in "JM Research S.C".
undefined are not yet recruiting,
1 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in JM Research S.C,
1 suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in JM Research S.C, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".